Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Elanco to become No. 2 in animal health with $7.6 billion Bayer deal

Elanco Animal Health agreed to buy Bayer’s veterinary drugs unit in a cash and stock deal valued at $7.6 billion, creating the second-largest maker of medicines for pets and livestock and expanding Elanco’s reach online.

Read More »

Bayer sells Dr. Scholl’s footcare brand to Yellow Wood Partners

Germany’s Bayer signed a deal to sell the company’s Dr. Scholl’s footcare brand to U.S. private investment firm Yellow Wood Partners for $585 million.

Read More »

Merck & Co. planning restructuring program

Merck & Co. filed with the U.S. Securities and Exchange Commission that the company plans an extensive restructuring of its manufacturing and supply network.

Read More »

Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip

Eli Lilly reported lower-than-expected first-quarter 2019 sales for the company’s top-selling diabetes drug Trulicity, due in part to patient affordability programs.

Read More »

Merck Buys Animal Health Company Antelliq

Merck & Co. is paying about $2.4 billion to acquire all outstanding shares of Antelliq Group, and is also assuming the digital technology company’s debt of $1.3 billion.

Read More »

Bayer To Slash 12,000 Employees, Aims To Strengthen Life Science Business

Bayer will cut 12,000 jobs as the company prepares a business overhaul, including an exit from the animal health division.

Read More »

Bayer CEO backs group’s diversified structure

Bayer’s chief executive reaffirmed his support for a corporate structure made up of healthcare, crop science and animal health businesses, after analysts called for a breakup to shore up the company’s flagging share price.

Read More »

Animal health firm Elanco surges 36 percent in debut

Elanco Animal Health’s shares climbed 36 percent in their stock market debut, in a sign of investor enthusiasm for the fast-growing pet healthcare market.

Read More »

Eli Lilly to take animal health unit public, profit beats estimates

Eli Lilly and Co. will take the company’s Elanco animal health business public and posted better-than-expected quarterly profit, helped by demand for the diabetes drugs Trulicity and Humalog.

Read More »

FDA approves Kindred treatment for problem weight loss in cats

Kindred Biosciences Inc. received the first U.S. approval for a treatment for unintended weight loss in cats.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom